Citigroup Inc Singular Genomics Systems, Inc. Transaction History

Citigroup Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.37 - $0.99 $37 - $99	-100 Reduced 77.52%	29 $0
Q2 2023 Aug 10, 2023	BUY	$0.78 - $1.28 $100 - $165	129 New	129 $0
Q4 2022 Feb 09, 2023	SELL	$1.82 - $2.71 $762 - $1,135	-419 Reduced 24.72%	1,276 $2,000
Q3 2022 Nov 10, 2022	SELL	$2.5 - $4.73 $8,420 - $15,930	-3,368 Reduced 66.52%	1,695 $4,000
Q2 2022 Aug 10, 2022	SELL	$2.86 - $6.44 $63,560 - $143,122	-22,224 Reduced 81.45%	5,063 $19,000
Q1 2022 May 12, 2022	SELL	$5.94 - $12.09 $39,976 - $81,365	-6,730 Reduced 19.78%	27,287 $172,000
Q4 2021 Feb 10, 2022	BUY	$10.45 - $16.9 $341,380 - $552,089	32,668 Added 2421.65%	34,017 $393,000
Q3 2021 Nov 10, 2021	BUY	$10.9 - $27.63 $14,704 - $37,272	1,349 New	1,349 $15,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.4B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.